Acute retinal necrosis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) |
Tarek Nafee (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
The estimated incidence of ARN is approximately 6.3 per 100,000 individuals. Worldwide, the increase in [[immunocompromised]] and aged populations in most countries has been correlated with an increase in the incidence of acute retinal necrosis.<ref name="pmid22281865">{{cite journal |vauthors=Cochrane TF, Silvestri G, McDowell C, Foot B, McAvoy CE |title=Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study |journal=Eye (Lond) |volume=26 |issue=3 |pages=370–7; quiz 378 |year=2012 |pmid=22281865 |pmc=3298997 |doi=10.1038/eye.2011.338 |url=}}</ref> There is evidence that this incidence is underestimated due to biases in case adjudication and under-reporting of data.<ref name="pmid17504853">{{cite journal |vauthors=Muthiah MN, Michaelides M, Child CS, Mitchell SM |title=Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK |journal=Br J Ophthalmol |volume=91 |issue=11 |pages=1452–5 |year=2007 |pmid=17504853 |pmc=2095441 |doi=10.1136/bjo.2007.114884 |url=}}</ref><ref name="pmid18584564">{{cite journal| author=Usui Y, Goto H| title=Overview and diagnosis of acute retinal necrosis syndrome. | journal=Semin Ophthalmol | year= 2008 | volume= 23 | issue= 4 | pages= 275-83 | pmid=18584564 | doi=10.1080/08820530802111325 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18584564 }} </ref><ref name="pmid17264500">{{cite journal| author=Kezuka T, Atherton SS| title=Acute retinal necrosis. | journal=Chem Immunol Allergy | year= 2007 | volume= 92 | issue= | pages= 244-53 | pmid=17264500 | doi=10.1159/000099275 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17264500 }} </ref><ref name="pmid16282149">{{cite journal| author=Bonfioli AA, Eller AW| title=Acute retinal necrosis. | journal=Semin Ophthalmol | year= 2005 | volume= 20 | issue= 3 | pages= 155-60 | pmid=16282149 | doi=10.1080/08820530500232027 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16282149 }} </ref><ref name="ARNopth">{{cite journal| author=Chun HL, Missotten T, Salzmann J, Lightman SL | title=Acute Retinal Necrosis: Features, Management, and Outcomes | journal=Opthalmology | year=2007 | volume=114 | Issue=4 | pages=756-762 | url=http://www.sciencedirect.com/science/article/pii/S0161642006012073 }}</ref> | |||
===Age=== | ===Age=== | ||
Acute [[retinal]] [[necrosis]] (ARN) developed from [[Herpes simplex virus]] 1 and [[Varicella-zoster virus]] is most common among patients older than 50 years.<ref name="pmid25356955">{{cite journal |vauthors=Brydak-Godowska J, Borkowski P, Szczepanik S, Moneta-Wielgoś J, Kęcik D |title=Clinical manifestation of self-limiting acute retinal necrosis |journal=Med. Sci. Monit. |volume=20 |issue= |pages=2088–96 |year=2014 |pmid=25356955 |pmc=4226315 |doi=10.12659/MSM.890469 |url=}}</ref> [[Herpes simplex virus]] (HSV) 2 infection is more common among children and adolescents; the incidence of HSV-2-caused ARN is highest in children and young adults between age 9 and 22 years. | |||
===Gender=== | ===Gender=== | ||
There is no gender predisposition to acute [[retinal]] [[necrosis]]. | |||
===Race=== | ===Race=== | ||
There is no racial predisposition to acute [[retinal]] [[necrosis]]. | |||
==References== | ==References== | ||
Revision as of 13:22, 14 September 2016
|
Acute retinal necrosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acute retinal necrosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Acute retinal necrosis epidemiology and demographics |
|
Acute retinal necrosis epidemiology and demographics in the news |
|
Blogs on Acute retinal necrosis epidemiology and demographics |
|
Risk calculators and risk factors for Acute retinal necrosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
Overview
The estimated incidence of acute retinal necrosis (ARN) is approximately 6.3 per 100,000 individuals. ARN that has developed from Herpes simplex virus 1 or Varicella-zoster virus is most common among patients older than 50 years, while the incidence of HSV-2 caused ARN is highest in children and young adults between age 9 and 22 years. There is no racial or gender predisposition to acute retinal necrosis.
Epidemiology and Demographics
Incidence
The estimated incidence of ARN is approximately 6.3 per 100,000 individuals. Worldwide, the increase in immunocompromised and aged populations in most countries has been correlated with an increase in the incidence of acute retinal necrosis.[1] There is evidence that this incidence is underestimated due to biases in case adjudication and under-reporting of data.[2][3][4][5][6]
Age
Acute retinal necrosis (ARN) developed from Herpes simplex virus 1 and Varicella-zoster virus is most common among patients older than 50 years.[7] Herpes simplex virus (HSV) 2 infection is more common among children and adolescents; the incidence of HSV-2-caused ARN is highest in children and young adults between age 9 and 22 years.
Gender
There is no gender predisposition to acute retinal necrosis.
Race
There is no racial predisposition to acute retinal necrosis.
References
- ↑ Cochrane TF, Silvestri G, McDowell C, Foot B, McAvoy CE (2012). "Acute retinal necrosis in the United Kingdom: results of a prospective surveillance study". Eye (Lond). 26 (3): 370–7, quiz 378. doi:10.1038/eye.2011.338. PMC 3298997. PMID 22281865.
- ↑ Muthiah MN, Michaelides M, Child CS, Mitchell SM (2007). "Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK". Br J Ophthalmol. 91 (11): 1452–5. doi:10.1136/bjo.2007.114884. PMC 2095441. PMID 17504853.
- ↑ Usui Y, Goto H (2008). "Overview and diagnosis of acute retinal necrosis syndrome". Semin Ophthalmol. 23 (4): 275–83. doi:10.1080/08820530802111325. PMID 18584564.
- ↑ Kezuka T, Atherton SS (2007). "Acute retinal necrosis". Chem Immunol Allergy. 92: 244–53. doi:10.1159/000099275. PMID 17264500.
- ↑ Bonfioli AA, Eller AW (2005). "Acute retinal necrosis". Semin Ophthalmol. 20 (3): 155–60. doi:10.1080/08820530500232027. PMID 16282149.
- ↑ Chun HL, Missotten T, Salzmann J, Lightman SL (2007). "Acute Retinal Necrosis: Features, Management, and Outcomes". Opthalmology. 114: 756–762. Unknown parameter
|Issue=ignored (|issue=suggested) (help) - ↑ Brydak-Godowska J, Borkowski P, Szczepanik S, Moneta-Wielgoś J, Kęcik D (2014). "Clinical manifestation of self-limiting acute retinal necrosis". Med. Sci. Monit. 20: 2088–96. doi:10.12659/MSM.890469. PMC 4226315. PMID 25356955.